Effects of aging on angiogenesis

Circulation Research

Volumn 110, Issue 9, 2012, Pages 1252-1263

  Lähteenvuo, Johanna ^a,b   Rosenzweig, Anthony ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Aging; Angiogenesis

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; ASCORBIC ACID; BUB1 RELATED PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2D; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7; THIOREDOXIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

AGED; AGING; ANGIOGENESIS; ATHEROSCLEROTIC PLAQUE; BLOOD FLOW; BLOOD VESSEL FUNCTION; CARDIOVASCULAR DISEASE; CELL AGING; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPOXIA; NONHUMAN; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; TELOMERE HOMEOSTASIS; VASODILATATION;

AGE FACTORS; AGING; ANGIOGENIC PROTEINS; ANIMALS; CARDIOVASCULAR DISEASES; CELL AGING; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; OXIDATIVE STRESS; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84860757532     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.111.246116     Document Type: Review

References (169)

1. Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003;9: 653-660.
2. Scholz D, Cai WJ, Schaper W. Arteriogenesis, a new concept of vascular adaptation in occlusive disease. Angiogenesis. 2001;4:247-257.
3. Jin SW, Patterson C. The opening act: Vasculogenesis and the origins of circulation. Arterioscler Thromb Vasc Biol. 2009;29:623-629.
4. Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G, Cooper M, Laznik D, Chinsomboon J, Rangwala S, Baek K, Rosenzweig A, Spiegelman B. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature. 2008;451: 1008-1012.
5. Yan Z, Okutsu M, Akhtar YN, Lira V. Regulation of exercise-induced fiber type transformation, mitochondrial biogenesis, and angiogenesis in skeletal muscle. J Appl Physiol. 2011;110:264-274.
6. Isner JM, Losordo DW. Therapeutic angiogenesis for heart failure. Nat Med. 1999;5:491-492.
7. Eilken HM, Adams RH. Dynamics of endothelial cell behavior in sprouting angiogenesis. Curr Opin Cell Biol. 2010;22:617-625.
8. Ballard VL, Edelberg JM. Stem cells and the regeneration of the aging cardiovascular system. Circ Res. 2007;100:1116-1127.
9. Kirton JP, Xu Q. Endothelial precursors in vascular repair. Microvasc Res. 2010;79:193-199.
10. Rosenzweig A. Circulating endothelial progenitors-cells as biomarkers. N Engl J Med. 2005;353:1055-1057.
11. Khurana R, Simons M, Martin JF, Zachary I. Role of angiogenesis in cardiovascular disease: A critical appraisal. Circulation. 2005;112: 1813-1824.
12. Fong GH. Mechanisms of adaptive angiogenesis to tissue hypoxia. Angiogenesis. 2008;11:121-140.
13. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: Role of the HIF system. Nat Med. 2003;9:677-684.
14. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson S, Thistlethwaite P. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med. 2000;342:626-633.
15. Safran M, Kaelin WG Jr. HIF hydroxylation and the mammalian oxygen-sensing pathway. J Clin Invest. 2003;111:779-783.
16. Chinsomboon J, Ruas J, Gupta RK, Thom R, Shoag J, Rowe G, Sawada N, Raghuram S, Arany Z. The transcriptional coactivator PGC-1alpha mediates exercise-induced angiogenesis in skeletal muscle. Proc Natl Acad Sci USA. 2009;106:21401-21406.
17. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473:298-307.
18. Ouriel K, Veith F. Acute lower limb ischemia: Determinants of outcome. Surgery. 1998;124:336-341; discussion 341-332.
19. Gavin TP, Ruster RS, Carrithers JA, Zwetsloot KA, Kraus RM, Evans CA, Knapp DJ, Drew JL, McCartney JS, Garry JP, Hickner RC. No difference in the skeletal muscle angiogenic response to aerobic exercise training between young and aged men. J Physiol. 2007;585:231-239.
20. Parizkova J, Eiselt E, Sprynarova S, Wachtlova M. Body composition, aerobic capacity, and density of muscle capillaries in young and old men. J Appl Physiol. 1971;31:323-325.
21. Coggan AR, Spina RJ, King DS, Rogers M, Brown M, Nemeth P, Holloszy J. Skeletal muscle adaptations to endurance training in 60-to 70-yr-old men and women. J Appl Physiol. 1992;72:1780-1786.
22. Gupta R, Tongers J, Losordo DW. Human studies of angiogenic gene therapy. Circ Res. 2009;105:724-736.
23. Rivard A, Fabre JE, Silver M, Chen D, Murohara T, Kearney M, Magner M, Asahara T, Isner JM. Age-dependent impairment of angiogenesis. Circulation. 1999;99:111-120.
24. Swift ME, Kleinman HK, DiPietro LA. Impaired wound repair and delayed angiogenesis in aged mice. Lab Invest. 1999;79:1479-1487.
25. Rossiter HB, Howlett RA, Holcombe HH, Entin PL, Wagner HE, Wagner PD. Age is no barrier to muscle structural, biochemical and angiogenic adaptations to training up to 24 months in female rats. J Physiol. 2005;565:993-1005.
26. Pili R, Guo Y, Chang J, Nakanishi H, Martin G, Passaniti A. Altered angiogenesis underlying age-dependent changes in tumor growth. J Natl Cancer Inst. 1994;86:1303-1314.
27. Gates PE, Strain WD, Shore AC. Human endothelial function and microvascular ageing. Exp Physiol. 2009;94:311-316.
28. Freedman DA. Senescence and its bypass in the vascular endothelium. Front Biosci. 2005;10:940-950.
29. Collins CJ, Sedivy JM. Involvement of the INK4a/Arf gene locus in senescence. Aging Cell. 2003;2:145-150.
30. Yang DG, Liu L, Zheng XY. Cyclin-dependent kinase inhibitor p16(INK4a) and telomerase may co-modulate endothelial progenitor cells senescence. Ageing Res Rev. 2008;7:137-146.
31. Lundberg AS, Hahn WC, Gupta P, et al. Genes involved in senescence and immortalization. Curr Opin Cell Biol. 2000;12:705-709.
32. Dai J, Zhu X, Yoder MC, Wu Y, Colman R. Cleaved high-molecularweight kininogen accelerates the onset of endothelial progenitor cell senescence by induction of reactive oxygen species. Arterioscler Thromb Vasc Biol. 2011;31:883-889.
33. Huschtscha LI, Reddel RR. p16(INK4a) and the control of cellular proliferative life span. Carcinogenesis. 1999;20:921-926.
34. Kawagishi H, Nakamura H, Maruyama M, Mizutani S, Sugimoto K, Takagi M, Sugimoto M. ARF suppresses tumor angiogenesis through translational control of VEGFA mRNA. Cancer Res. 2010;70: 4749-4758.
35. Watanabe Y, Lee SW, Detmar M, Ajioka I, Dvorak H. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells. Oncogene. 1997;14:2025-2032.
36. Samani NJ, Erdmann J, Hall AS, et al. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357:443-453.
37. Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007;316:1491-1493.
38. McPherson R. Chromosome 9p21 and coronary artery disease. N Engl J Med. 2010;362:1736-1737.
39. Fuster JJ, Andres V. Telomere biology and cardiovascular disease. Circ Res. 2006;99:1167-1180.
40. Blasco MA. Telomeres and human disease: Ageing, cancer and beyond. Nat Rev Genet. 2005;6:611-622.
41. Chiu CP, Dragowska W, Kim NW, Vaziri H, Yui J, Thomas T, Harley C, Lansdorp P. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells. 1996; 14:239-248.
42. Chang E, Harley CB. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA. 1995;92:11190-11194.
43. Hastings R, Qureshi M, Verma R, Lacy P, Williams B. Telomere attrition and accumulation of senescent cells in cultured human endothelial cells. Cell Prolif. 2004;37:317-324.
44. Samani NJ, Boultby R, Butler R, Thompson J, Goodall A. Telomere shortening in atherosclerosis. Lancet. 2001;358:472-473.
45. Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I. Endothelial cell senescence in human atherosclerosis: Role of telomere in endothelial dysfunction. Circulation. 2002;105:1541-1544.
46. Franco S, Segura I, Riese HH, et al. Decreased B16F10 melanoma growth and impaired vascularization in telomerase-deficient mice with critically short telomeres. Cancer Res. 2002;62:552-559.
47. Erusalimsky JD, Skene C. Mechanisms of endothelial senescence. Exp Physiol. 2009;94:299-304.
48. Yang J, Chang E, Cherry AM, Bangs C, Oei Y, Bodnar A, Bronstein A, Chiu C, Herron G. Human endothelial cell life extension by telomerase expression. J Biol Chem. 1999;274:26141-26148.
49. Matsushita H, Chang E, Glassford AJ, Cooke J, Chiu C, Tsao P. eNOS activity is reduced in senescent human endothelial cells: Preservation by hTERT immortalization. Circ Res. 2001;89:793-798.
50. Murasawa S, Llevadot J, Silver M, Isner J, Losordo D, Asahara T. Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation. 2002;106:1133-1139.
51. Yang J, Nagavarapu U, Relloma K, Sjaastad M, Moss W, Passaniti A, Herron G. Telomerized human microvasculature is functional in vivo. Nat Biotechnol. 2001;19:219-224.
52. Veitonmaki N, Fuxe J, Hultdin M, Roos G, Pettersson R, Cao Y. Immortalization of bovine capillary endothelial cells by hTERT alone involves inactivation of endogenous p16INK4a/pRb. FASEB J. 2003; 17:764-766.
53. Jaskelioff M, Muller FL, Paik JH, Thomas E, Jiang S, Adams AC, Sahin E, Kost-Alimova M, Protopopov A, Cadiñanos J, Horner JW, Maratos-Flier E, DePinho RA. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature. 2011;469: 102-106.
54. Sahin E, Colla S, Liesa M, et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature. 2011;470:359-365.
55. Arany Z, He H, Lin J, et al. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab. 2005;1:259-271.
56. Arany Z, Novikov M, Chin S, Ma Y, Rosenzweig A, Spiegelman BM. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha. Proc Natl Acad Sci UthsS A. 2006;103:10086-10091.
57. Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, Kirkland JL, van Deursen JM. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011;479: 232-236.
58. Baker DJ, Jeganathan KB, Cameron JD, Thompson M, Juneja S, Kopecka A, Kumar R, Jenkins RB, de Groen PC, Roche P, van Deursen JM. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet. 2004;36:744-749.
59. Matsumoto T, Baker DJ, d'Uscio LV, Mozammel G, Katusic ZS, van Deursen JM. Aging-associated vascular phenotype in mutant mice with low levels of BubR1. Stroke. 2007;38:1050-1056.
60. Muller FL, Lustgarten MS, Jang Y, Richardson A, Van Remmen H. Trends in oxidative aging theories. Free Radic Biol Med. 2007;43: 477-503.
61. Sohal RS, Sohal BH. Hydrogen peroxide release by mitochondria increases during aging. Mech Ageing Dev. 1991;57:187-202.
62. Lee HC, Chang CM, Chi CW. Somatic mutations of mitochondrial DNA in aging and cancer progression. Ageing Res Rev. 2010;9(Suppl 1):S47-S58.
63. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107:1058-1070.
64. Csiszar A, Ungvari Z, Edwards J, Kaminski P, Wolin M, Koller A, Kaley G. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res. 2002;90:1159-1166.
65. Carrao AC, Chilian WM, Yun J, Kolz C, Rocic P, Lehmann K, van den Wijngaard JP, van Horssen P, Spaan JA, Ohanyan V, Pung YF, Buschmann I. Stimulation of coronary collateral growth by granulocyte stimulating factor: Role of reactive oxygen species. Arterioscler Thromb Vasc Biol. 2009;29:1817-1822.
66. Ushio-Fukai M, Tang Y, Fukai T, Dikalov SI, Ma Y, Fujimoto M, Quinn MT, Pagano PJ, Johnson C, Alexander RW. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factorinduced signaling and angiogenesis. Circ Res. 2002;91:1160-1167.
67. Tojo T, Ushio-Fukai M, Yamaoka-Tojo M, Ikeda S, Patrushev N, Alexander RW. Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation. 2005; 111:2347-2355.
68. Ushio-Fukai M, Alexander RW. Reactive oxygen species as mediators of angiogenesis signaling: Role of NAD(P)H oxidase. Mol Cell Biochem. 2004;264:85-97.
69. Zanetti M, Zwacka R, Engelhardt J, Katusic Z, O'Brien T. Superoxide anions and endothelial cell proliferation in normoglycemia and hyperglycemia. Arterioscler Thromb Vasc Biol. 2001;21:195-200.
70. Cai H. Hydrogen peroxide regulation of endothelial function: Origins, mechanisms, and consequences. Cardiovasc Res. 2005;68:26-36.
71. Kurz DJ, Decary S, Hong Y, Trivier E, Akhmedov A, Erusalimsky J. Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. J Cell Sci. 2004; 117:2417-2426.
72. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N Engl J Med. 2000;342:154-160.
73. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson J, Glynn R, Gaziano J. Vitamins E and C in the prevention of cardiovascular disease in men: The physicians' health study II randomized controlled trial. JAMA. 2008;300:2123-2133.
74. Zhang H, Luo Y, Zhang W, He Y, Dai S, Zhang R, Huang Y, Bernatchez P, Giordano F, Shadel G, Sessa W, Min W. Endothelial-specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions. Am J Pathol. 2007;170: 1108-1120.
75. Furumoto K, Inoue E, Nagao N, Hiyama E, Miwa N. Age-dependent telomere shortening is slowed down by enrichment of intracellular vitamin C via suppression of oxidative stress. Life Sci. 1998;63: 935-948.
76. Haendeler J, Hoffmann J, Diehl JF, Vasa M, Spyridopoulos I, Zeiher A, Dimmeler S. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ Res. 2004;94:768-775.
77. Bode-Boger SM, Martens-Lobenhoffer J, Tager M, Schroder H, Scalera F. Aspirin reduces endothelial cell senescence. Biochem Biophys Res Commun. 2005;334:1226-1232.
78. Hirooka Y, Eshima K, Setoguchi S, Kishi T, Egashira K, Takeshita A. Vitamin C improves attenuated angiotensin II-induced endotheliumdependent vasodilation in human forearm vessels. Hypertens Res. 2003; 26:953-959.
79. Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pandolfi P, Lanfrancone L, Pelicci P. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature. 1999;402:309-313.
80. Zhou S, Chen HZ, Wan YZ, Zhang QJ, Wei YS, Huang S, Liu JJ, Lu YB, Zhang ZQ, Yang RF, Zhang R, Cai H, Liu DP, Liang CC. Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. Circ Res. 2011;109:639-648.
81. Francia P, delli Gatti C, Bachschmid M, Martin-Padura I, Savoia C, Migliaccio E, Pelicci PG, Schiavoni M, Luscher TF, Volpe M, Cosentino F. Deletion of p66shc gene protects against age-related endothelial dysfunction. Circulation. 2004;110:2889-2895.
82. Napoli C, Martin-Padura I, de Nigris F, Giorgio M, Mansueto G, Somma P, Condorelli M, Sica G, De Rosa G, Pelicci P. Deletion of the p66shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc Natl Acad Sci USA. 2003;100:2112-2116.
83. Yamamori T, White AR, Mattagajasingh I, Khanday FA, Haile A, Qi B, Jeon BH, Bugayenko A, Kasuno K, Berkowitz DE, Irani K. P66shc regulates endothelial NO production and endothelium-dependent vasorelaxation: Implications for age-associated vascular dysfunction. J Mol Cell Cardiol. 2005;39:992-995.
84. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes J, Fishman M, Huang P, Isner J. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998;101:2567-2578.
85. Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa W. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest. 1997;100: 3131-3139.
86. Ozuyaman B, Ebner P, Niesler U, Ziemann J, Kleinbongard P, Jax T, Godecke A, Kelm M, Kalka C. Nitric oxide differentially regulates proliferation and mobilization of endothelial progenitor cells but not of hematopoietic stem cells. Thromb Haemost. 2005;94:770-772.
87. Davis ME, Cai H, Drummond GR, Harrison D. Shear stress regulates endothelial nitric oxide synthase expression through c-Src by divergent signaling pathways. Circ Res. 2001;89:1073-1080.
88. Hayashi T, Matsui-Hirai H, Miyazaki-Akita A, Fukatsu A, Funami J, Ding Q, Kamalanathan S, Hattori Y, Ignarro L, Iguchi A. Endothelial cellular senescence is inhibited by nitric oxide: Implications in atherosclerosis associated with menopause and diabetes. Proc Natl Acad Sci USA. 2006;103:17018-17023.
89. Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J. 2009;73:411-418.
90. Forstermann U, Sessa W. Nitric oxide synthases: Regulation and function. Eur Heart J. 2011 Sep 1. [Epub ahead of print].
91. Sessa WC. eNOS at a glance. J Cell Sci. 2004;117:2427-2429.
92. Barton M, Cosentino F, Brandes RP, Moreau P, Shaw S, Luscher T. Anatomic heterogeneity of vascular aging: Role of nitric oxide and endothelin. Hypertension. 1997;30:817-824.
93. Yoon HJ, Cho SW, Ahn BW, Yang S. Alterations in the activity and expression of endothelial NO synthase in aged human endothelial cells. Mech Ageing Dev. 2010;131:119-123.
94. Kim JH, Bugaj LJ, Oh YJ, et al. Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J Appl Physiol. 2009;107:1249-1257.
95. Smith AR, Visioli F, Frei B, Hagen T. Age-related changes in endothelial nitric oxide synthase phosphorylation and nitric oxide dependent vasodilation: Evidence for a novel mechanism involving sphingomyelinase and ceramide-activated phosphatase 2A. Aging Cell. 2006;5: 391-400.
96. Bach MH, Sadoun E, Reed MJ. Defects in activation of nitric oxide synthases occur during delayed angiogenesis in aging. Mech Ageing Dev. 2005;126:467-473.
97. Sindler AL, Delp MD, Reyes R, Wu G, Muller-Delp J. Effects of ageing and exercise training on eNOS uncoupling in skeletal muscle resistance arterioles. J Physiol. 2009;587:3885-3897.
98. Yang YM, Huang A, Kaley G, Sun D. eNOS uncoupling and endothelial dysfunction in aged vessels. Am J Physiol Heart Circ Physiol. 2009; 297:H1829-H1836.
99. van der Loo B, Labugger R, Skepper JN, Bachschmid M, Kilo J, Powell JM, Palacios-Callender M, Erusalimsky JD, Quaschning T, Malinski T, Gygi D, Ullrich V, Lüscher TF. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med. 2000;192:1731-1744.
100. Beckman J, Beckman T, Chen J, Marshall P, Freeman B. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 1990;87:1620-1624.
101. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters B, Karoui H, Tordo P, Pritchard KJ. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors. Proc Natl Acad Sci USA. 1998;95:9220-9225.
102. Chou TC, Yen MH, Li CY, Ding Y. Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension. 1998;31: 643-648.
103. Rivard A, Berthou-Soulie L, Principe N, Kearney M, Curry C, Branellec D, Semenza GL, Isner JM. Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J Biol Chem. 2000;275:29643-29647.
104. Ahluwalia A, Narula J, Jones MK, Deng X, Tarnawski A. Impaired angiogenesis in aging myocardial microvascular endothelial cells is associated with reduced importin alpha and decreased nuclear transport of HIF1 alpha: Mechanistic implications. J Physiol Pharmacol. 2010; 61:133-139.
105. Rajagopalan S, Olin J, Deitcher S, Pieczek A, Laird J, Grossman P, Goldman C, McEllin K, Kelly R, Chronos N. Use of a constitutively active hypoxia-inducible factor-1alpha transgene as a therapeutic strategy in no-option critical limb ischemia patients: Phase I doseescalation experience. Circulation. 2007;115:1234-1243.
106. Bosch-Marce M, Okuyama H, Wesley JB, et al. Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res. 2007;101: 1310-1318.
107. Cheng XW, Kuzuya M, Kim W, Song H, Hu L, Inoue A, Nakamura K, Di Q, Sasaki T, Tsuzuki M, Shi G, Okumura K, Murohara T. Exercise training stimulates ischemia-induced neovascularizat ion via phosphatidylinositol 3-kinase/Akt-dependent hypoxia-induced factor-1 alpha reactivation in mice of advanced age. Circulation. 2010;122:707-716.
108. Weinstein RS, Wan C, Liu Q, Wang Y, Almeida M, O'Brien C, Thostenson J, Roberson P, Boskey A, Clemens T, Manolagas S. Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell. 2010;9:147-161.
109. Lim JH, Lee YM, Chun YS, Chen J, Kim J, Park J. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol Cell. 2010;38:864-878.
110. Ferrara N. VEGF-A: A critical regulator of blood vessel growth. Eur Cytokine Netw. 2009;20:158-163.
111. Wagner PD, Olfert IM, Tang K, Breen E. Muscle-targeted deletion of VEGF and exercise capacity in mice. Respir Physiol Neurobiol. 2006; 151:159-166.
112. Wagatsuma A. Effect of aging on expression of angiogenesis-related factors in mouse skeletal muscle. Exp Gerontol. 2006;41:49-54.
113. Ryan NA, Zwetsloot KA, Westerkamp LM, et al. Lower skeletal muscle capillarization and VEGF expression in aged vs. young men. J Appl Physiol. 2006;100:178-185.
114. Croley AN, Zwetsloot KA, Westerkamp LM, Ryan N, Pendergast A, Hickner R, Pofahl W, Gavin T. Lower capillarization, VEGF protein, and VEGF mRNA response to acute exercise in the vastus lateralis muscle of aged vs. Young women. J Appl Physiol. 2005;99:1872-1879.
115. Xaymardan M, Zheng J, Duignan I, Chin A, Holm J, Ballard V, Edelberg J. Senescent impairment in synergistic cytokine pathways that provide rapid cardioprotection in the rat heart. J Exp Med. 2004;199: 797-804.
116. Garfinkel S, Hu X, Prudovsky IA, McMahon G, Kapnik E, McDowell S, Maciag T. FGF-1-dependent proliferative and migratory responses are impaired in senescent human umbilical vein endothelial cells and correlate with the inability to signal tyrosine phosphorylation of fibroblast growth factor receptor-1 substrates. J Cell Biol. 1996;134: 783-791.
117. Iemitsu M. Exercise training improves aging-induced downregulation of vegf angiogenic signaling cascade in hearts. AJP Heart Circ Physiol. 2006;291:H1290-H1298.
118. Leosco D, Rengo G, Iaccarino G, et al. Prior exercise improves agedependent vascular endothelial growth factor downregulation and angiogenesis responses to hind-limb ischemia in old rats. J Gerontol A Biol Sci Med Sci. 2007;62:471-480.
119. Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature. 2009;460:587-591.
120. Haigis MC, Sinclair DA. Mammalian sirtuins: Biological insights and disease relevance. Annu Rev Pathol. 2010;5:253-295.
121. Tissenbaum HA, Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature. 2001;410:227-230.
122. Viswanathan M, Guarente L. Regulation of Caenorhabditis elegans lifespan by sir-2.1 transgenes. Nature. 2011;477:E1-E2.
123. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337-342.
124. Wood JG, Rogina B, Lavu S, Howitz K, Helfand S, Tatar M, Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature. 2004;430:686-689.
125. Howitz KT, Bitterman KJ, Cohen HY, Lamming D, Lavu S, Wood J, Zipkin R, Chung P, Kisielewski A, Zhang L, Scherer B, Sinclair D. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003;425:191-196.
126. Burnett C, Valentini S, Cabreiro F, et al. Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature. 2011; 477:482-485.
127. Stein S, Matter CM. Protective roles of SIRT1 in atherosclerosis. Cell Cycle. 2011;10:640-647.
128. Ota H, Akishita M, Eto M, Iijima K, Kaneki M, Ouchi Y. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J Mol Cell Cardiol. 2007;43:571-579.
129. Nisoli E, Tonello C, Cardile A, Cozzi V, Bracale R, Tedesco L, Falcone S, Valerio A, Cantoni O, Clementi E, Moncada S, Carruba MO. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science. 2005;310:314-317.
130. Mattagajasingh I, Kim CS, Naqvi A, Yamamori T, Hoffman TA, Jung S-B, DeRicco J, Kasuno K, Irani K. SIRT1 promotes endotheliumdependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci USA. 2007;104:14855-14860.
131. Zhang QJ, Wang Z, Chen HZ, Zhou S, Zheng W, Liu G, Wei Y-S, Cai H, Liu D-P, Liang C-C. Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res. 2008;80:191-199.
132. Qiang L, Lin HV, Kim-Muller JY, Welch CL, Gu W, Accili D. Proatherogenic abnormalities of lipid metabolism in SirT1 transgenic mice are mediated through Creb deacetylation. Cell Metab. 2011;14: 758-767.
133. Boodhwani M, Sellke FW. Therapeutic angiogenesis in diabetes and hypercholesterolemia: Influence of oxidative stress. Antiox Redox Signal. 2009;11:1945-1959.
134. Van Craenenbroeck EM, Conraads VM. Endothelial progenitor cells in vascular health: Focus on lifestyle. Microvasc Res. 2010;79:184-192.
135. Humar R, Zimmerli L, Battegay E. Angiogenesis and hypertension: An update. J Hum Hypertens. 2009;23:773-782.
136. Ballard V, Edelberg J. Harnessing hormonal signaling for cardioprotection. Sci Aging Knowledge Environ. 2005;2005:re6.
137. Lantin-Hermoso RL, Rosenfeld CR, Yuhanna IS, German Z, Chen Z, Shaul P. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol. 1997;273: L119-L126.
138. Rubanyi GM, Johns A, Kauser K. Effect of estrogen on endothelial function and angiogenesis. Vascul Pharmacol. 2002;38:89-98.
139. Grasselli A, Nanni S, Colussi C, Aiello A, Benvenuti V, Ragone G, Moretti F, Sacchi A, Bacchetti S, Gaetano C, Capogrossi M, Pontecorvi A, Farsetti A. Estrogen receptor-alpha and endothelial nitric oxide synthase nuclear complex regulates transcription of human telomerase. Circ Res. 2008;103:34-42.
140. Imanishi T, Hano T, Nishio I. Estrogen reduces endothelial progenitor cell senescence through augmentation of telomerase activity. J Hypertens. 2005;23:1699-1706.
141. Iwakura A, Luedemann C, Shastry S, Hanley A, Kearney M, Aikawa R, Isner J, Asahara T, Losordo D. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation. 2003;108:3115-3121.
142. Imanishi T, Hano T, Nishio I. Estrogen reduces angiotensin II-induced acceleration of senescence in endothelial progenitor cells. Hypertens Res. 2005;28:263-271.
143. Farsetti A, Grasselli A, Bacchetti S, Gaetano C, Capogrossi M. The telomerase tale in vascular aging: Regulation by estrogens and nitric oxide signaling. J Appl Physiol. 2009;106:333-337.
144. Sieveking DP, Chow RW, Ng MK. Androgens, angiogenesis and cardiovascular regeneration. Curr Opin Endocrinol Diabetes Obes. 2010; 17:277-283.
145. Rossouw JE, Anderson GL, Prentice RL, LaCroix A, Kooperberg C, Stefanick M, Jackson R, Beresford S, Howard B, Johnson K, Kotchen J, Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
146. Bittner V. Postmenopausal hormone therapy and the risk of cardiovascular disease. Expert Opin Pharmacother. 2009;10:2041-2053.
147. Forstermann U, Li H. Therapeutic effect of enhancing endothelial nitric oxide synthase (enos) expression and preventing enos uncoupling. Br J Pharmacol. 2011;164:213-223.
148. Lake-Bruse KD, Faraci FM, Shesely EG, Maeda N, Sigmund C, Heistad D. Gene transfer of endothelial nitric oxide synthase (eNOS) in eNOSdeficient mice. Am J Physiol. 1999;277:H770-H776.
149. Namba T, Koike H, Murakami K, Aoki M, Makino H, Hashiya N, Ogihara T, Kaneda Y, Kohno M, Morishita R. Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model. Circulation. 2003;108:2250-2257.
150. Antoniades C, Bakogiannis C, Leeson P, et al. Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling. Circulation. 2011;124:335-345.
151. Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ, Sessa WC, Walsh K. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med. 2000;6:1004-1010.
152. Duan J, Murohara T, Ikeda H, Katoh A, Shintani S, Sasaki K, Kawata H, Yamamoto N, Imaizumi T. Hypercholesterolemia inhibits angiogenesis in response to hindlimb ischemia: Nitric oxide-dependent mechanism. Circulation. 2000;102:III370-III376.
153. Sindler AL, Fleenor BS, Calvert JW, Marshall K, Zigler M, Lefer D, Seals D. Nitrite supplementation reverses vascular endothelial dysfunction and large elastic artery stiffness with aging. Aging Cell. 2011; 10:429-437.
154. Brodsky SV, Gealekman O, Chen J, Zhang F, Togashi N, Crabtree M, Gross S, Nasjletti A, Goligorsky M. Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen. Circ Res. 2004;94:377-384.
155. Calvert JW, Condit ME, Aragon JP, Nicholson C, Moody B, Hood R, Sindler A, Gundewar S, Seals D, Barouch L, Lefer D. Exercise protects against myocardial ischemia-reperfusion injury via stimulation of beta(3)-adrenergic receptors and increased nitric oxide signaling: Role of nitrite and nitrosothiols. Circ Res. 2011;108:1448-1458.
156. Yu J. An engineered vegf-activating zinc finger protein transcription factor improves blood flow and limb salvage in advanced-age mice. FASEB J. 2006;20:479-481.
157. Pola R, Ling LE, Silver M, Corbley M, Kearney M, Blake Pepinsky R, Shapiro R, Taylor F, Baker D, Asahara T, Isner J. The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat Med. 2001;7:706-711.
158. Zaccagnini G, Gaetano C, Della Pietra L, et al. Telomerase mediates vascular endothelial growth factor-dependent responsiveness in a rat model of hind limb ischemia. J Biol Chem. 2005;280:14790-14798.
159. Roy H, Bhardwaj S, Babu M, Lahteenvuo J, Yla-Herttuala S. VEGFDdeltaNdeltaC mediated angiogenesis in skeletal muscles of diabetic WHHL rabbits. Eur J Clin Invest. 2010;40:422-432.
160. Kastrup J, Jorgensen E, Ruck A, Tagil K, Glogar D, Ruzyllo W, Botker H, Dudek D, Drvota V, Hesse B, Thuesen L, Blomberg P, Gyongyosi M, Sylven C. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris a randomized double-blind placebo-controlled study: The Euroinject One trial. J Am Coll Cardiol. 2005;45:982-988.
161. Grines CL, Watkins MW, Helmer G, Penny W, Brinker J, Marmur J, West A, Rade J, Marrott P, Hammond H, Engler R. Angiogenic gene therapy (AGENT) trial in patients with stable angina pectoris. Circulation. 2002;105:1291-1297.
162. Henry TD, Annex BH, McKendall GR, et al. The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation. 2003;107:1359-1365.
163. Yla-Herttuala S, Markkanen JE, Rissanen TT. Gene therapy for ischemic cardiovascular diseases: Some lessons learned from the first clinical trials. Trends Cardiovasc Med. 2004;14:295-300.
164. Song Z, von Figura G, Liu Y, Kraus J, Torrice C, Dillon P, Rudolph-Watabe M, Ju Z, Kestler H, Sanoff H, Lenhard Rudolph K. Lifestyle impacts on the aging-associated expression of biomarkers of DNA damage and telomere dysfunction in human blood. Aging Cell. 2010;9: 607-615.
165. Puterman E, Lin J, Blackburn E, O'Donovan A, Adler N, Epel E. The power of exercise: Buffering the effect of chronic stress on telomere length. PLoS One. 2010;5:e10837.
166. Ludlow AT, Zimmerman JB, Witkowski S, Hearn J, Hatfield B, Roth S. Relationship between physical activity level, telomere length, and telomerase activity. Med Sci Sports Exerc. 2008;40:1764-1771.
167. Luk T, Dai Y, Siu C, Yiu K, Chan H, Lee S, Li S, Fong B, Wong W, Tam S, Lau C, Tse H. Effect of exercise training on vascular endothelial function in patients with stable coronary artery disease: A randomized controlled trial. Eur J Cardiovasc Prev Rehabil. 2011 Jul [Epub ahead of print].
168. Schlager O, Giurgea A, Schuhfried O, Seidinger D, Hammer A, Groger M,
169. Van Craenenbroeck EM, Hoymans VY, Beckers PJ, Possemiers N, Wuyts K, Paelinck B, Vrints C, Conraads V. Exercise training improves function of circulating angiogenic cells in patients with chronic heart failure. Basic Res Cardiol. 2010;105:665-676.